Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 3.300
-0.300 (-8.33%)
Aug 24, 2026, 11:10 AM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 639.7 million as of August 27, 2026. Its market cap has decreased by -41.59% in one year.
Market Cap
639.70M
Enterprise Value
670.52M
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
ChartMarket Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 639.70M, a decrease of -79.28%. That is a compound annual growth rate of -41.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 639.70M | -58.85% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cloudbreak Pharma | 979.70M |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 871.57M |
| JW (Cayman) Therapeutics Co. | 817.88M |
| 3D Medicines | 750.06M |
| Brii Biosciences | 743.46M |
| Cutia Therapeutics | 723.10M |
| B&K Corporation | 619.47M |